AstraZeneca's China plant wins ISPE award; TPG completes buyout of Pharmatech, becomes Adare;

> AstraZeneca's ($AZN) plant in Taizhou, China won the ISPE award in project execution for being completed in 20 months and 18% under budget. Release

> A new report says the global active pharmaceutical ingredient market will hit $185.9 billion by 2020, with a compounded average growth rate of 6.5% during the forecast period from 2014 to 2020. Release

> TPG has completed its acquisition of Aptalis Pharmaceutical Technologies, known as Pharmatech, from Actavis ($ACT) and has renamed itself Adare Pharmaceuticals. Release

> Greenwich, CT-based Aptuit has increased its API manufacturing capacity at facilities in England and Italy for development work and clinical trials. Release

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.